Navigation Links
Idea to Arm Cancer Patients with Information Specific to Their Disease and Treatment Receives Nod, Grant from American Cancer Society
Date:11/12/2008

ns that will be treating them.

"We thought an individual DVD would help solve a lot of these issues. We're thrilled that the American Cancer Society agrees with us," Demers said.

The information provided on the DVD is tailored to the latest evidence-based clinical practice guidelines available through the ACS database. Treatment recommendations are specific, and include performance measurement.

"To my knowledge, we are the first organization to develop this tool to educate patients about their particular type of cancer and how they actively participate in their care," Demers said. "We encourage our patients to use the DVD with their family, or to bring the DVD along for a second opinion so that there aren't questions that go unasked."

The customized DVDs are already available for breast and lung cancers. Production is underway on DVDs and Web sites for prostate and colon cancers and lymphoma.

Because the DVD B-roll and physician introductions are specific to the hospital and physicians working with the individual patient, GLCI has rolled out the DVDs within its own network on a deliberate schedule. GLCI's Lansing, Michigan campus was the original development site for the breast cancer DVD and received an American Cancer Society award last year for their efforts. Affiliated GLCI centers in Flint, Bay City and Lapeer, Mich. are working to produce DVD information around other selected cancers to share across the GLCI network. The Ted B. Wahby Cancer Center at Mount Clemens Regional Medical Center will be able to provide the DVDs to patients by the end of the year.

"We think that a similar model could be used for patients being treated for any number of illnesses," Demers said. "Patients are already using the Internet to find information about their disease and treatment, but the big issue is finding information that's specific to you. This gives them a tool made just for them that offers real options specific to their illness.
'/>"/>

SOURCE McLaren Health Care
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Benign or cancerous?
2. New technology could revolutionize breast cancer screening
3. Calcium plus vitamin D supplementation is not associated with a reduced breast cancer risk
4. The miseries of allergies just may help prevent some cancers, study finds
5. Calcium, Vitamin D Wont Prevent Breast Cancer
6. LSUHSC public health contributes to estimate of HPV-related cancers
7. New technique to study the genetics of breast cancer
8. Over 200 Patients and Families Create a Human Chain to Open A New Home for the Winthrop-University Hospital Cancer Center for Kids
9. Bone cancer treatment ineffective, despite promising laboratory data
10. Karmanos Cancer Institute Seeks Breast Cancer Patients to Participate in a New Drug Trial
11. Sexual intimacy and breast cancer survivors: New research
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 2FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 3FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 4China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 2China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 3China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 4China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 5China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 6China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 7China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 8CBI Announces FDA Participation at Upcoming Forum on Clinical Trial Investigator Portals 14631 1CBI Announces FDA Participation at Upcoming Forum on Clinical Trial Investigator Portals 14631 2CBI Announces FDA Participation at Upcoming Forum on Clinical Trial Investigator Portals 14631 3Novavax and CPL Biologicals Break Ground on New Influenza Vaccine Manufacturing Facility in India 14627 1Novavax and CPL Biologicals Break Ground on New Influenza Vaccine Manufacturing Facility in India 14627 2Novavax and CPL Biologicals Break Ground on New Influenza Vaccine Manufacturing Facility in India 14627 3Novavax and CPL Biologicals Break Ground on New Influenza Vaccine Manufacturing Facility in India 14627 4Novavax and CPL Biologicals Break Ground on New Influenza Vaccine Manufacturing Facility in India 14627 5Breast Health is a Year Round Priority 3A New Technology Identifies Risk of Breast Cancer in Younger Women 5779 1Breast Health is a Year Round Priority 3A New Technology Identifies Risk of Breast Cancer in Younger Women 5779 2Breast Health is a Year Round Priority 3A New Technology Identifies Risk of Breast Cancer in Younger Women 5779 3